ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ENTX vs SRZN // 10Y YIELD & FRED MACRO BETA

Entera Bio Ltd. (NASDAQ) VS. Surrozen Inc. (NASDAQ) • 15-METRIC TALLY: ENTX 4 — SRZN 0
■ METRIC PARITY
macro-sensitivity
—
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENTX VS. SRZN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ENTX SRZN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 0.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -33.60% -35.00% +1.40 ENTX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.38% -5.79% +4.41 ENTX /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% -65.00% 0.00 TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.4 59.1 +0.30 ENTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $542.6M $524.4M $18.2M ENTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ENTX REV SRZN REV ENTX GROSS % SRZN GROSS % ENTX FCF SRZN FCF
FY 2025 $42.0K $3.5M 0.0% — -$7.5M -$30.4M
FY 2024 $181.0K $10.7M 5.0% — -$6.8M -$17.7M
FY 2023 $0 $0 — — -$7.3M -$40.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENTX // BETA —
SRZN // BETA —